I would have to listen again, you could be correct with that.
I don’t see why it would take too long to complete the study. Btm and the competitors product are already both FDA approved product. The trial is simply comparing results like Time in bed, elasticity, cosmetic differences, infection rate, take rate, quality of life after recovery etc etc. I have no medical background at all this is just my interpretation.
I know they did mentioned about PMA approval for btm by the end of 2025 CY.
- Forums
- ASX - By Stock
- PNV
- PNV - Chart
PNV - Chart, page-19492
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.45 |
Change
-0.040(1.61%) |
Mkt cap ! $1.664B |
Open | High | Low | Value | Volume |
$2.45 | $2.46 | $2.38 | $1.856M | 767.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 6911 | $2.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.46 | 15733 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 15941 | 2.420 |
19 | 24261 | 2.410 |
16 | 44386 | 2.400 |
19 | 43012 | 2.390 |
15 | 66776 | 2.380 |
Price($) | Vol. | No. |
---|---|---|
2.430 | 9660 | 16 |
2.440 | 64422 | 22 |
2.450 | 61738 | 16 |
2.460 | 25081 | 13 |
2.470 | 17924 | 7 |
Last trade - 11.58am 27/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |